335 524

Cited 8 times in

How to use immune checkpoint inhibitor in ovarian cancer?

DC Field Value Language
dc.contributor.author김성훈-
dc.contributor.author박준식-
dc.contributor.author이정윤-
dc.date.accessioned2019-12-18T01:01:19Z-
dc.date.available2019-12-18T01:01:19Z-
dc.date.issued2019-
dc.identifier.issn2005-0380-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/173324-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherAsian Society of Gynecologic Oncology : Taehan Puin Chongyang Hakhoe-
dc.relation.isPartOfJOURNAL OF GYNECOLOGIC ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHCarcinoma, Ovarian Epithelial*-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHImmunotherapy-
dc.subject.MESHNeoplasm Recurrence, Local-
dc.subject.MESHOvarian Neoplasms*-
dc.subject.MESHProgrammed Cell Death 1 Receptor-
dc.titleHow to use immune checkpoint inhibitor in ovarian cancer?-
dc.title.alternative.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Obstetrics and Gynecology (산부인과학교실)-
dc.contributor.googleauthorJunsik Park-
dc.contributor.googleauthorJung-Yun Lee-
dc.contributor.googleauthorSunghoon Kim-
dc.identifier.doi10.3802/jgo.2019.30.e105-
dc.contributor.localIdA00595-
dc.contributor.localIdA05788-
dc.contributor.localIdA04638-
dc.relation.journalcodeJ01428-
dc.identifier.eissn2005-0399-
dc.identifier.pmid31328467-
dc.contributor.alternativeNameKim, Sung Hoon-
dc.contributor.affiliatedAuthor김성훈-
dc.contributor.affiliatedAuthor박준식-
dc.contributor.affiliatedAuthor이정윤-
dc.citation.volume30-
dc.citation.number5-
dc.citation.startPagee105-
dc.identifier.bibliographicCitationJOURNAL OF GYNECOLOGIC ONCOLOGY, Vol.30(5) : e105, 2019-
dc.identifier.rimsid63860-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Obstetrics and Gynecology (산부인과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.